An up-close look at a new way of taking medicine: a matchstick-size device that when implanted under the skin releases a steady, continuous, and low-dose stream of medicine. Intarcia Therapeutics Inc. is now focused on delivering a drug for diabetes, but the possibilities don’t end there. Could this approach be used to stave off HIV, malaria and other infections?
-Kurt Graves, Chairman, President, and CEO, Intarcia
- See more at: http://www.fortuneconferences.com/brainstorm-health-2017/2017-agenda-overview/#sthash.rxjCO37t.dpuf
Subscribe to Fortune -
http://www.youtube.com/subscription_center?add_user=FortuneMagazineVideo
FORTUNE is a global leader in business journalism with a worldwide circulation of more than 1 million and a readership of nearly 5 million, with major franchises including the FORTUNE 500 and the FORTUNE 100 Best Companies to Work For. FORTUNE Live Media extends the brand's mission into live settings, hosting a wide range of annual conferences, including the FORTUNE Global Forum.
Website: http://fortune.com/
Facebook: https://www.facebook.com/FortuneMagazine
Twitter: https://twitter.com/FortuneMagazine
Fortune Magazine is published by Time Inc.
